← FDA DRUG APPROVALS

FDA ANDA · ANDA077651

ZONISAMIDE

Sponsor: GLENMARK PHARMS

APPLICATION
ANDA077651
TYPE
ANDA
ORIGINAL APPROVAL
2006-01-30
LATEST ACTION
2022-05-25
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ZONISAMIDEPrescription
ZONISAMIDE 25MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 50MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 100MG · CAPSULE · ORAL

Approval history

2022-05-25Labeling · Supplement 17 · standardAP
2016-07-18Labeling · Supplement 15 · standardAP
2015-10-26Labeling · Supplement 13 · standardAP
2015-06-13Labeling · Supplement 11 · standardAP
2012-05-30Labeling · Supplement 10AP
2010-02-26Labeling · Supplement 8AP
2007-09-12Labeling · Supplement 2AP
2006-05-01Labeling · Supplement 1AP
2006-01-30OriginalHealthcare Professional SheetAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →